A pesticide introduced in 2013 as a lower-risk alternative to neonicotinoids may still be disrupting bee reproduction at the molecular level, even at exposure doses too low to produce obvious symptoms. Researchers at the Georgia Institute of Technology report that low-dose exposure to sulfoxaflor measurably changes gene activity in worker bumblebees, with the largest effects concentrated in ovarian tissue — the reproductive organ most directly tied to a colony’s ability to produce new queens and workers.
The findings, published in the journal Ecotoxicology and Environmental Safety (Michael A. Catto, Jixiang Xu, Kayla A. Murray, Emma Leigh M. Bossard, Michael A.D. Goodisman, and Sarah E. Orr; DOI: 10.1016/j.ecoenv.2026.120101), used RNA sequencing and computational modeling to trace how gene expression shifts across bumblebee tissues after sulfoxaflor exposure at field-relevant, sub-lethal concentrations. The research was supported by the U.S. Department of Agriculture.
Why this matters for pesticide risk assessment
Sulfoxaflor is a sulfoximine-class insecticide developed and marketed as a next-generation alternative to neonicotinoids, which have been increasingly restricted in the United States and European Union over pollinator toxicity concerns. Because sulfoxaflor targets the same nicotinic acetylcholine receptor pathway in insects but is metabolized differently, it was positioned as a comparatively pollinator-safer option and has been approved for use on a wide range of food crops.
Regulatory risk assessments for agrochemicals have historically relied heavily on acute mortality and observable behavioral endpoints — does the pesticide kill bees outright, or visibly impair foraging and navigation, at a given dose. The Georgia Tech findings point to a different kind of risk: transcriptional-level disruption that would not necessarily be caught by mortality-based testing, but that plausibly affects a colony’s long-term reproductive output. The researchers link the molecular changes they observed to real-world consequences for colony health, a connection with direct relevance for how agencies such as the U.S. Environmental Protection Agency evaluate sub-lethal, chronic pesticide exposure in pollinator risk frameworks.
What the study found
Worker bumblebees exposed to low doses of sulfoxaflor showed significant shifts in gene expression, with the most pronounced changes occurring in ovarian tissue. That pattern is notable because bumblebee colonies, unlike honeybee colonies, depend on a comparatively small number of reproductive individuals; disruption at the level of ovarian gene activity in workers — some of which retain reproductive capacity under certain colony conditions — could plausibly compound into colony-level reproductive costs even when no bee dies from direct exposure.
The stakes extend well beyond bumblebees specifically. Pollinators collectively support roughly one-third of global food production by volume, making sub-lethal effects on wild and managed pollinator reproduction a food-security question as much as a conservation one.
An open methodological question: transcriptomic data and reproducibility
Studies that pair pesticide exposure with genome-wide transcriptomic profiling generate exactly the kind of dataset that benefits from public deposition in a repository such as the National Center for Biotechnology Information’s Gene Expression Omnibus (GEO), allowing other researchers to reanalyze the raw expression data, compare it against other pesticide-exposure datasets, or fold it into meta-analyses of pollinator toxicogenomics. CASRAI could not independently confirm from the published record whether this specific dataset has been deposited in GEO or an equivalent repository at the time of writing; readers seeking the underlying sequencing data should consult the paper’s data availability statement directly via the DOI above.
Context: from neonicotinoids to sulfoxaflor
The regulatory history here is part of what makes this study consequential. The EU imposed a near-total ban on the three major neonicotinoids blamed for pollinator declines starting in 2018, and sulfoxaflor was explicitly marketed and, in some jurisdictions, approved as part of the replacement generation of insecticides. If a compound engineered to sidestep neonicotinoid-style toxicity produces its own distinct sub-lethal reproductive signature, that has direct implications for how regulators evaluate the next generation of “safer” agrochemical replacements — not just sulfoxaflor itself.
What to watch next
- Whether EPA or EU regulators cite transcriptomic endpoints like this one in future sulfoxaflor re-registration reviews, alongside the mortality- and behavior-based endpoints currently used.
- Follow-up studies examining whether the ovarian gene-expression changes translate into measurable reductions in queen production or colony reproductive output under field conditions.
- Whether the underlying RNA-seq dataset is made publicly available, which would let independent groups verify and extend the findings.
Primary source: Catto, M.A., Xu, J., Murray, K.A., Bossard, E.L.M., Goodisman, M.A.D., & Orr, S.E. Study on sulfoxaflor and bumblebee gene expression. Ecotoxicology and Environmental Safety (2026). DOI: 10.1016/j.ecoenv.2026.120101.
